Sep 13, 2020 / 09:00PM GMT
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Gilead Sciences conference call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions)
I would now like to hand the conference over to your speaker today to Douglas Maffei, Senior Director, Investor Relations. Thank you. Please go ahead.
Douglas Maffei - Gilead Sciences, Inc. - Senior Director of IR
Thank you, Dilem. We appreciate everyone joining us on short notice for today's call to discuss the exciting acquisition of Immunomedics announced earlier today. The speakers on today's call will be Daniel O'Day, Chairman and Chief Executive Officer; Merdad Parsey, Chief Medical Officer; Johanna Mercier, Chief Commercial Officer; and Andrew Dickinson, Chief Financial Officer.
Before we begin, let me remind you that we will be making forward-looking statements that are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those referred to in any forward-looking statements.
Gilead Sciences Inc to Acquire Immunomedics Inc Conference Call Transcript
Sep 14, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers